Locked content Krka with €101.8 mln net profit in H1

Slovenian pharmaceutical company Krka reported H1 consolidated net profit of €101.8 million compared to €91.7 million y/y. Operating profit stood at €135.5 million versus €124.1 million in H1 2017.  EBITDA grew to €190.9 million from  €177.3 million y/y. Consolidated revenue in H1 rose to  €680.5 mi...

Locked content Krka will pay 2017 gross dividend of €2.9/shr

International pharmaceutical company Krka shareholders decided on payment of gross dividend of €2.9 per share for the fiscal year 2017. The company will allocate €92.8 million in total. The record date of the dividend is July 18. The dividend will be paid on July 19, 2018. Krka, Slovenia’s lar...